Latest Niacin Stories

2011-11-15 19:36:38

At an 8 a.m. EST press conference today at the American Heart Association meeting, UB professor of medicine William E. Boden, MD, discusses the AIM-HIGH clinical trial, which found that niacin provides no incremental benefit to patients with atherosclerotic heart disease, whose levels of LDL cholesterol and non-HDL (which contributes to plaque in the arteries) were very well-controlled. -- The study results are applicable only to this narrowly defined patient population, Boden notes. --...

2011-10-07 12:17:43

Kaiser Permanente study also finds heart attack and stroke risk increase when 'good' cholesterol levels go down Increasing levels of high-density lipoproteins, better known as HDL or "good" cholesterol, reduced the risk for heart attack and stroke among patients with diabetes. That's according to a new study appearing online today in The American Journal of Cardiology. The observational study, one of the largest of its kind, examined the medical records of more than 30,000 patients with...

2011-07-13 07:40:00

IRVINE, Calif., July 13, 2011 /PRNewswire/ -- ChromaDex Corp. (OTCBB.:CDXC) today announced that Cornell University has granted the natural products company ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside (NR). "Despite its potential to deliver significant health benefits, nicotinamide riboside, or NR, is currently not available to the market as a dietary ingredient," said Frank L. Jaksch, Jr., CEO of ChromaDex. "The technology we have...

2011-05-27 08:25:00

U.S. government researchers said on Thursday that giving a high dose of niacin to people with heart disease who are already taking a cholesterol-lowering statin does nothing more to prevent heart attacks and strokes. The findings challenge the notion that raising high-density lipoprotein (HDL) can further reduce heart risks in people who already have their low-density lipoprotein (LDL) under control. Patients in the study who had a history of heart disease were treated with Abbott...

2011-05-26 10:01:00

ABBOTT PARK, Ill., May 26, 2011 /PRNewswire/ -- The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), today disclosed results from an interim analysis of the AIM-HIGH clinical trial. AIM-HIGH was designed to test whether raising HDL and lowering triglycerides in a patient population with established cardiovascular disease and very well controlled LDL levels could produce an additional 25 percent benefit on cardiovascular outcomes. The...

2011-03-21 20:31:00

BOSTON, March 21, 2011 /PRNewswire/ -- Arisaph Pharmaceuticals, Inc., a privately held drug discovery biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's recently submitted Investigational New Drug (IND) application to evaluate ARI-3037MO in a phase I human clinical trial in healthy volunteers. ARI-3037MO, a proprietary new chemical entity, is a once-daily, niacin analog being developed for the treatment of...

Word of the Day
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.